Kidney cancer drug could slash the risk of repeated heart attacks in a similar way to statins, study suggests

Дата публикации: 01-09-2024 00:26:13

Cambridge University scientists found the anti-inflammatory medication, aldesleukin, reduced inflammation on a similar level to statins, cutting chances of a repeat attack.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	More than a million adults taking statins might not need them, study suggests - but experts urge caution	0	8.4	12-08-2026
2	A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease	0	9.7	07-08-2026
3	Exosome treatment may curb heart scarring after heart attacks	0	6.36	30-07-2026
4	Natural clotting 'switch' may one day reduce reliance on blood thinners to prevent heart attacks and strokes	0	6.03	23-07-2026
5	Study questions the value of intensive cardiac surveillance in cancer patients treated with anthracyclines	0	6.46	29-07-2026
6	Doctors thought this kidney drug helped some patients. It may help millions more.	0	6.28	08-06-2026
7	Redesigned lung cancer drug matches tumor control with fewer off-target interactions	0	9.72	24-07-2026
8	STAT+: Heart failure drug from Tenax Therapeutics fails in pivotal study	0	5.33	10-08-2026
9	Low-Dose Rivaroxaban and Cardiovascular Events in Advanced Kidney Disease	0	8.74	28-07-2026
10	After weight loss, exercise improves cardiovascular health more than weight-loss medication	2	6	08-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.9. Источник: www.dailymail.co.uk.